Literature DB >> 29203373

Betulinic, oleanolic and ursolic acids inhibit the enzymatic and biological effects induced by a P-I snake venom metalloproteinase.

Lina María Preciado1, Paola Rey-Suárez1, Isabel Cristina Henao2, Jaime Andrés Pereañez3.   

Abstract

Betulinic acid (BA), Oleanolic acid (OA) and Ursolic acid (UA), are pentacyclic triterpenoids with widespread occurrence throughout the plant kingdom, these compounds are widely recognized by their pharmacological and biological properties, such as, anti-tumoral, anti-inflammatory, anti-microbial and hepatoprotective activity. In this work we determined the inhibitory ability of these compounds on the enzymatic, hemorrhagic, myotoxic and edema-inducing activities of Batx-I, a P-I metalloproteinase isolated from Bothrops atrox venom. BA, UA and OA inhibited the proteolytic activity of Batx-I on gelatin with IC50 values of 115.3, 223.0 and 357.3 μM, respectively. Additionally, these compounds showed inhibition of the hemorrhagic activity of Batx-I in skin with IC50 345.7, 643.5 and 1077.0 μM for BA, UA and OA in preincubation experiments. In studies with independent-injection, in which Batx-I was injected and then, at the same site, a concentration of 600 μM of each compound were administered at either 0, 5 or 10 min, BA showed a significant reduction of hemorrhage at 0 and 5 min. In addition, these compounds inhibited myotoxicity and edema-forming activity of Batx-I at 600 μM concentration. Molecular docking studies suggested that these compounds could occupy part of the substrate binding cleft of the enzyme affecting its catalytic cycle. In this manner, triterpenic acids are candidates for the development of inhibitors for the prevention of local tissue damage in snakebite envenomation.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Local tissue damage; Metalloproteinase; Molecular docking; Snake venom; Triterpenic acids

Mesh:

Substances:

Year:  2017        PMID: 29203373     DOI: 10.1016/j.cbi.2017.12.001

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  7 in total

1.  Therapeutic Outcome of Anti-inflammatory and Antioxidative Medicines on the Dermonecrotic Activity of Cerastes cerastes Venom.

Authors:  Abderrezak Khelfi; Habiba Oussedik-Oumehdi; Fatima Laraba-Djebari
Journal:  Inflammation       Date:  2022-03-05       Impact factor: 4.092

Review 2.  Plant-Derived Toxin Inhibitors as Potential Candidates to Complement Antivenom Treatment in Snakebite Envenomations.

Authors:  Asenate A X Adrião; Aline O Dos Santos; Emilly J S P de Lima; Jéssica B Maciel; Weider H P Paz; Felipe M A da Silva; Manuela B Pucca; Ana M Moura-da-Silva; Wuelton M Monteiro; Marco A Sartim; Hector H F Koolen
Journal:  Front Immunol       Date:  2022-05-09       Impact factor: 8.786

3.  Interactions between Triterpenes and a P-I Type Snake Venom Metalloproteinase: Molecular Simulations and Experiments.

Authors:  Lina María Preciado; Jaime Andrés Pereañez; Ettayapuram Ramaprasad Azhagiya Singam; Jeffrey Comer
Journal:  Toxins (Basel)       Date:  2018-09-28       Impact factor: 4.546

4.  Inhibition of a Snake Venom Metalloproteinase by the Flavonoid Myricetin.

Authors:  Lina María Preciado; Jeffrey Comer; Vitelbina Núñez; Paola Rey-Súarez; Jaime Andrés Pereañez
Journal:  Molecules       Date:  2018-10-16       Impact factor: 4.411

5.  Ursolic Acid-Induced Apoptosis via Regulation of the PI3K/Akt and MAPK Signaling Pathways in Huh-7 Cells.

Authors:  Kwong-Chiu Lee; Yao-Li Chen; Ping-Yi Lin; Wan-Ling Chuang
Journal:  Molecules       Date:  2018-08-13       Impact factor: 4.411

6.  Potential of Matrix Metalloproteinase Inhibitors for the Treatment of Local Tissue Damage Induced by a Type P-I Snake Venom Metalloproteinase.

Authors:  Lina María Preciado; Jaime Andrés Pereañez; Jeffrey Comer
Journal:  Toxins (Basel)       Date:  2019-12-20       Impact factor: 4.546

Review 7.  Perspective on the Therapeutics of Anti-Snake Venom.

Authors:  Isabel Gómez-Betancur; Vedanjali Gogineni; Andrea Salazar-Ospina; Francisco León
Journal:  Molecules       Date:  2019-09-09       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.